Evidence map›Paper›PMID 19444907›Full record

Trial reportInternational journal of cancer2009

Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.

Amber B Moore, Jackilen Shannon, Chu Chen, Johanna W Lampe, Roberta M Ray, Sharon K Lewis, Minggang Lin, Helge Stalsberg, David B Thomas

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Targeting ferroptosis in breast cancer.Biomarker research · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Amber B MooreDepartment of Public Health and Preventive Medicine, Oregon Health and Sciences University, Portland, 97239, USA. mooreamb@ohsu.edu
Jackilen Shannon
Chu Chen
Johanna W Lampe
Roberta M Ray
Sharon K Lewis
Minggang Lin
Helge Stalsberg
David B Thomas
Fred Hutch Cancer Center · USOregon Health & Science University · USUiT The Arctic University of Norway · NO

Funding

DIET, CELL PROLIFERATION AND BREAST CANCER IN SHANGHAIR01CA075332 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1997 to 2001
$923k
NCI NIH HHS R01 CA075332NCI NIH HHS R01-CA75332
6 · The paper itself

Abstract

Increases in risk of breast cancer in successive generations of migrants to the United States from China and rapid temporal changes in incidence rates in China following social and economic changes clearly implicate environmental factors in the etiology of this disease. Case-control and cohort studies have provided evidence that at least some of these factors may be dietary. Iron, an essential element necessary for cell function, has also been demonstrated to have potential carcinogenic and co-carcinogenic activities. Iron overload, which was previously uncommon, has become more common in the United States than iron deficiency and may be increasing in China concurrently with dramatic increases in meat consumption. A case-control study nested in a cohort of women in Shanghai, China, was conducted to evaluate possible associations between risk of proliferative and nonproliferative fibrocystic changes as well as breast cancer and dietary iron intake and plasma ferritin levels. Plasma ferritin levels and reported dietary iron intake were compared in 346 women with fibrocystic changes, 248 breast cancer cases and 1,040 controls. Increasing ferritin levels were significantly associated with increasing risk of nonproliferative fibrocystic changes (OR: 2.51, 95% CI: 1.16-5.45, p trend = 0.04). Similar, but weaker, trends were observed for proliferative changes and for breast cancer. Risk of breast cancer relative to the risk of fibrocystic changes was associated with dietary iron intake in women with nonproliferative fibrocystic changes (OR: 2.63, 95% CI: 1.04-6.68, p = 0.02). In conclusion, this study finds significant associations between iron (stored and dietary) and fibrocystic disease and breast cancer.

Indexed as

Iron, DietaryAdultBreast NeoplasmsCase-Control StudiesChinaFemaleFerritinsFibrocystic Breast DiseaseHumansIron CompoundsMiddle AgedRisk FactorsFerritinsIron CompoundsIron, Dietary

Identifiers

PMID19444907
PMCPMC2798105
OpenAlexW2112137905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.